Stock

Almeda Ventures Limited Partnership

AMDA.TA

Asset Management · Financial Services

Price

255.20 ILA

+0.00 (+0.00%)

Market Cap

49.5M ILA

Exchange

Tel Aviv Stock Exchange

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Sep 17, 2026 · filings through Jun 30, 2026

§How the score breaks down

Quality

Exceptional

Growth

Mixed

Cash Flow

Weak

Stability

Good

Valuation

Good

Dividends

Good

Track this stock — start free trial

Share count falling — buybacks

−9.6% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 18.7M (2021) → 16.9M (2025)

§Winston Score History

The full picture

Almeda Ventures Limited Partnership, established in Tel Aviv, Israel, in 2020, functions as a venture capital firm. The partnership strategically deploys capital across various development stages, including seed, startup, early-stage, and established middle-market companies. Its core investment thesis centers on health technology innovation, with a particular emphasis on medical devices, digital health solutions, bio-convergence, and public R&D collaborations. Additionally, Almeda Ventures allocates funds to life sciences research and development enterprises. Geographically, the firm primarily focuses its investments within Israel, the United States, and Europe.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

100.0%

Premium pricing power — 100.0% gross margin

Profit after running costs

Operating Margin

95.1%

Excellent — 95.1% operating margin

Return on the money invested

ROCE

32.3%

Exceptional — 32.3% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

-10%

Weak — only -10% of profit becomes cash

Spare cash per sale

FCF Margin

-9.1%

Burning cash (-9.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

100.00x

Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

1.6x

Attractive valuation — P/E 1.6

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

47.68%

Healthy income — 47.68% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record

Dividend Growth

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial